全文获取类型
收费全文 | 20775篇 |
免费 | 1092篇 |
国内免费 | 150篇 |
专业分类
耳鼻咽喉 | 220篇 |
儿科学 | 452篇 |
妇产科学 | 205篇 |
基础医学 | 2313篇 |
口腔科学 | 367篇 |
临床医学 | 1452篇 |
内科学 | 5850篇 |
皮肤病学 | 435篇 |
神经病学 | 1585篇 |
特种医学 | 784篇 |
外科学 | 3888篇 |
综合类 | 49篇 |
预防医学 | 497篇 |
眼科学 | 396篇 |
药学 | 1099篇 |
中国医学 | 48篇 |
肿瘤学 | 2377篇 |
出版年
2024年 | 31篇 |
2023年 | 194篇 |
2022年 | 391篇 |
2021年 | 685篇 |
2020年 | 373篇 |
2019年 | 462篇 |
2018年 | 623篇 |
2017年 | 410篇 |
2016年 | 574篇 |
2015年 | 539篇 |
2014年 | 760篇 |
2013年 | 875篇 |
2012年 | 1383篇 |
2011年 | 1617篇 |
2010年 | 895篇 |
2009年 | 803篇 |
2008年 | 1312篇 |
2007年 | 1360篇 |
2006年 | 1320篇 |
2005年 | 1382篇 |
2004年 | 1422篇 |
2003年 | 1285篇 |
2002年 | 1168篇 |
2001年 | 185篇 |
2000年 | 166篇 |
1999年 | 200篇 |
1998年 | 240篇 |
1997年 | 226篇 |
1996年 | 160篇 |
1995年 | 136篇 |
1994年 | 144篇 |
1993年 | 109篇 |
1992年 | 87篇 |
1991年 | 74篇 |
1990年 | 59篇 |
1989年 | 45篇 |
1988年 | 39篇 |
1987年 | 41篇 |
1986年 | 33篇 |
1985年 | 18篇 |
1984年 | 29篇 |
1983年 | 22篇 |
1982年 | 23篇 |
1981年 | 17篇 |
1980年 | 17篇 |
1979年 | 10篇 |
1978年 | 10篇 |
1977年 | 9篇 |
1976年 | 9篇 |
1975年 | 12篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
941.
Yujiro Nagata Takashi Kawahara Takuro Goto Satoshi Inoue Yuki Teramoto Guiyang Jiang Naohiro Fujimoto Hiroshi Miyamoto 《American journal of cancer research》2020,10(12):4386
We recently demonstrated that silodosin, a selective α1-blocker often prescribed for the symptomatic treatment of benign prostatic hyperplasia (BPH), could inactivate a c-fos proto-oncogene regulator ELK1 in bladder cancer cells possessing a functional androgen receptor (AR). However, the clinical impact of α1-blockers on the development and progression of bladder cancer remained poorly understood. In the present study, we investigated if α1-blockers clinically used, including silodosin, tamsulosin, and naftopidil, could prevent the neoplastic/malignant transformation and cell growth, using non-neoplastic urothelial SVHUC sublines with carcinogen/MCA challenge and bladder cancer lines, respectively. Bladder cancers in men treated with silodosin, tamsulosin, or naftopidil for their BPH were then compared. Silodosin at 1-10 µM significantly inhibited the neoplastic transformation of MCA-SVHUC-AR cells, but not that of AR-negative MCA-SVHUC-control cells. In MCA-SVHUC-AR, silodosin significantly reduced the expression levels of oncogenes (c-fos/NF-κB1) and induced those of tumor suppressors (p27/PTEN). However, tamsulosin (up to 1 µM) or naftopidil (up to 10 µM) failed to significantly inhibit the neoplastic transformation of AR-positive or AR-negative urothelial cells. Similarly, cell proliferation/migration of AR-positive bladder cancer lines was considerably inhibited only by silodosin. Meanwhile, the incidence of bladder cancer in patients with silodosin [49/540 (9.1%)] was marginally lower, compared to those with tamsulosin [64/523 (12.2%); P=0.094] or tamsulosin or naftopidil [64+28/523+236 (12.1%); P=0.082]. There were no significant differences in tumor grade/stage among the 3 cohorts. Outcome analysis revealed lower risks for disease progression of non-muscle-invasive bladder tumors in the silodosin group than in the naftopidil group (P=0.011) or tamsulosin+naftopidil groups (P=0.035). Similarly, silodosin patients with muscle-invasive tumor had lower risks for disease progression, compared with tamsulosin (P=0.006) or tamsulosin+naftopidil (P=0.028) patients. Multivariate analysis further showed that silodosin treatment in those with non-muscle-invasive tumor was associated with improved progression-free survival, compared with naftopidil (hazard ratio=0.086; 95% confidence interval=0.008-0.905; P=0.041) or tamsulosin/naftopidil (hazard ratio=0.128; 95% confidence interval=0.016-1.036; P=0.054) treatment. Our in vitro studies thus indicate that both urothelial tumorigenesis and tumor growth are inhibited by silodosin, but not by tamsulosin or naftopidil. Clinical data further suggest that even pharmacological doses (e.g. 0.1 µM) of silodosin contribute to preventing bladder cancer progression. 相似文献
942.
Noji T Kondo S Hirano S Tanaka E Ambo Y Kawarada Y Morikawa T 《Journal of gastroenterology》2005,40(7):739-743
Background The extent of paraaortic lymph node (PAN) metastasis parellels that of distant metastases in patients with biliary carcinoma. Accurate preoperative assessment of PAN metastasis has a crucial impact on surgical indications. In this retrospective study, we evaluated whether computed tomography (CT) scans were useful for diagnosing PAN metastases and excluding patients with PAN metastases from an indication for surgery.Methods Between March 1999 and November 2003, 57 patients with biliary carcinoma underwent radical lymphadenectomy or surgical biopsy of PANs. Nine of these patients were diagnosed as having PAN metastasis microscopically. All patients had undergone abdominal CT scans before surgery. To diagnose PAN metastases, we used the following diagnostic criteria. (1) Size; when lymph nodes were greater than 12 mm, 10 mm, 8 mm, or 6 mm in longo or short-axis diameter, the nodes were considered metastatic. (2) Shape and size; when the axial ratio of a lymph node was greater than 0.5, 0.7, 1.0, and the maximum diameter of the long or short axis was greater than 12 mm, 10 mm, 8 mm, or 6 mm, the node was considered metastatic. (3) Internal structure; if the internal structure of a PAN was heterogeneous, the node was considered metastatic. A positive predictive value was calculated for each included criterion when patients numbered ten or more.Results Positive predictive values using the above criteria ranged from 13% to 36%. Only one patient had PANs with heterogeneous internal structures.Conclusions We were unable to determine surgical indications based on the morphological criteria revealed by a CT scan. 相似文献
943.
Sakai F Noma S Kurihara Y Yamada H Azuma A Kudoh S Ichikawa Y 《Modern rheumatology / the Japan Rheumatism Association》2005,15(3):173-179
Imaging findings of 26 cases of leflunomide (Arava)-related acute lung injury were analyzed. Thirteen cases had pre-existing interstitial pulmonary disease on chest X-ray or computed tomography. The main features of clinically determined leflunomide-induced acute lung injury were similar to those caused by other drugs: diffuse or widespread patchy ground-glass opacities and/or consolidation, frequently accompanied by septal thickening and intralobular reticular opacities. We categorized these findings into four patterns: diffuse alveolar damage (DAD), acute eosinophilic pneumonia, hyperreaction, and cryptogenic organizing pneumonia. The DAD group had a higher mortality rate, but statistically not a significant one. It is impossible to exclude infectious disease such as pneumocystis carinii pneumonia based on imaging findings, and detailed correlation of imaging findings with clinical and laboratory findings is essential in order to make a correct diagnosis. 相似文献
944.
Differential diagnosis of pancreatic cancer and focal pancreatitis by using EUS-guided FNA 总被引:11,自引:0,他引:11
Takahashi K Yamao K Okubo K Sawaki A Mizuno N Ashida R Koshikawa T Ueyama Y Kasugai K Hase S Kakumu S 《Gastrointestinal endoscopy》2005,61(1):76-79
BACKGROUND: Despite advances in diagnostic imaging techniques, the differentiation between pancreatic cancer and focal pancreatitis remains difficult. This study evaluated the effectiveness of EUS-guided FNA in the differential diagnosis between pancreatic cancer and focal pancreatitis, with particular reference to detection of the K-ras point mutation. METHODS: The study included 62 consecutive patients with pancreatic ductal cancer and 15 patients with focal pancreatitis demonstrated as a pancreatic mass lesion by EUS. RESULTS: Sensitivity, specificity, overall accuracy, positive predictive value, and negative predictive value of cytopathologic diagnosis were 82%, 100%, 86%, 100%, and 58%, respectively. Sensitivity, specificity, overall accuracy, positive predictive value, and negative predictive value of histopathologic diagnosis were 44%, 100%, 55%, 100%, and 32%, respectively. The K-ras point mutation was found in 74% of pancreatic cancers and 0% of focal pancreatitis lesions. No complication of EUS-guided FNA was observed. CONCLUSIONS: EUS-guided FNA is useful for the differential diagnosis of pancreatic mass lesions caused by pancreatic cancer and focal pancreatitis. Analysis for the K-ras point mutation in specimens obtained by EUS-guided FNA may enhance diagnostic accuracy in indeterminate cases. 相似文献
945.
Hideyuki Ogawa Toshiyuki Ishikawa Kouhei Matsushita Katsumi Matsumoto Tomoaki Ishigami Teruyasu Sugano Kazuaki Uchino Satoshi Umemura Shinichi Sumita Kazuo Kimura Takeshi Nakagawa Makoto Shimizu Hideo Nishikawa Atsunobu Kasai Yukio Kioka 《Circulation journal》2008,72(5):700-704
BACKGROUND: Several preliminary studies have indicated that atrial pacing can prevent atrial tachyarrhythmias. The suggested mechanisms by which pacing may be effective include suppression of premature atrial beats. METHODS AND RESULTS: The Atrial Pacing Preference (APP; Guidant, St Paul, MN, USA) algorithm allows the pacemaker to maintain a pacing rate slightly higher than the sinus rate. The preventive effects of APP on paroxysmal atrial fibrillation (AF) were studied in 51 patients (70+/-11 years). Nine patients did not complete the protocol. The pacemaker was programmed in random order to APP off and APP on at 3 different settings (ie, 8, 16 and 32 cycles) for 4 weeks each, using a cross-over design. Percentage atrial pacing was lower in APP off than at the other settings. Premature beat counts were greater in APP off than at the other settings. There was a significant difference in mode switch episode counts between APP off and the most effective setting (3,818+/-15,356 vs 596+/-1,719; p<0.01). CONCLUSIONS: The APP algorithm is a promising method for preventing atrial tachyarrhythmia in patients with an implanted pacemaker and AF. Optimizing the setting of the APP algorithm is an important issue in the prevention of AF. 相似文献
946.
Yamano T Nakatani S Kanzaki H Toh N Amaki M Tanaka J Abe H Hasegawa T Sawada T Matsubara H Kitakaze M 《The American journal of cardiology》2008,102(4):481-485
It has remained unclear why functional mitral regurgitation (MR), even if it is of a mild degree, has prognostic importance in patients with idiopathic dilated cardiomyopathy (IDC). Exercise-induced changes in functional MR, which might be a clue to this question, have not been fully clarified. Thus, in this study, semisupine exercise echocardiography was performed on 32 asymptomatic or mildly symptomatic patients with IDC (29 men, mean age 45 +/- 14 years). The mean ejection fraction was 28 +/- 10% (range 13% to 45%). The effective regurgitant orifice (ERO) area of MR was measured, as well as echocardiographic parameters including mitral valve geometry. ERO at rest was associated best with systolic mitral tenting area (r(S) = 0.85, p <0.001). Functional MR did not newly appear during exercise in 9 subjects without MR at rest. In the remaining 23 subjects with functional MR at rest, all showed exacerbations of MR, with a median ERO of 10.5 mm(2) (interquartile range 6.3 to 16.5) to 18.7 mm(2) (interquartile range 9.5 to 29.3) (p <0.001). An increase in ERO was correlated best with the enlargement of tenting area (r(S) = 0.90, p <0.001) and was the strongest independent determinant of exercise duration (beta = -0.55, p = 0.002, multiple R(2) = 0.46). In conclusion, functional MR complicated with IDC was significantly exacerbated during exercise, with mitral valve deformation, which was strongly related to exercise intolerance; thus, the clinical impact of functional MR in patients with IDC could be more serious than can be expected by its degree at rest. 相似文献
947.
Suzuki T Tsutsumi A Suzuki H Suzuki E Sugihara M Muraki Y Hayashi T Chino Y Goto D Matsumoto I Ito S Miyazawa K Sumida T 《Modern rheumatology / the Japan Rheumatism Association》2008,18(5):472-479
Tristetraprolin (TTP) is an intracellular protein that modulates the production of cytokines, including TNFα, by binding to
and destabilizing the mRNAs of these cytokines. Therefore, differences in TTP gene expression may affect the severity of inflammatory
diseases, such as rheumatoid arthritis (RA). We searched for polymorphisms in the human TTP gene and for this purpose, we
sequenced the entire TTP gene in 20 Japanese individuals (ten with RA and ten healthy volunteers) and found one single nucleotide
polymorphism (SNP) in the promoter region. We analyzed this SNP (A/G) by restriction fragment length polymorphism method in
155 RA patients and 100 control subjects. While the frequency of A allele in this SNP was similar in RA patients (74.5%) and
controls (76.0%), the disease duration in RA patients with genotype GG was shorter than that of patients with genotypes AA/AG
and RA patients with genotype GG had a higher probability of being treated with infliximab. We studied the difference in promoter
activity between the two alleles by luciferase assay and found that the promoter activity of TTP promoter region with allele
A was around two-fold higher than that with allele G. We conclude that this SNP in the promoter region of the TTP gene mildly
affects promoter activity, and thus, may influence the disease activity of inflammatory disorders including RA. 相似文献
948.
Plasma interleukin-6 and tumor necrosis factor-alpha can predict coronary endothelial dysfunction in hypertensive patients. 总被引:4,自引:0,他引:4
Masanao Naya Takahiro Tsukamoto Koichi Morita Chietsugu Katoh Tomoo Furumoto Satoshi Fujii Nagara Tamaki Hiroyuki Tsutsui 《Hypertension research》2007,30(6):541-548
Coronary endothelial function is impaired in hypertension; however, the severity of this impairment varies among patients. We aimed to identify the predictors of coronary endothelial dysfunction among clinical variables related to hypertension and atherosclerosis. Twenty-seven untreated, uncomplicated essential hypertensive patients and 10 age-matched healthy controls were studied prospectively. Myocardial blood flow (MBF) was measured by using (15)O-water positron emission tomography (PET) at rest and during a cold pressor test (CPT). Coronary vascular resistance (CVR) during CPT was used as a marker of coronary endothelial function. Serum low density lipoprotein (LDL) cholesterol, high density lipoprotein (HDL) cholesterol, triglycerides, malondialdehyde-LDL, homeostasis model assessment, high-sensitivity C-reactive protein (hs-CRP), and plasma interleukin-6 (IL-6) and tumor necrosis factor (TNF)-alpha were also measured. CVR during CPT was significantly higher in hypertensive patients than in healthy controls (114+/-26 vs. 94+/-12 mmHg/[mL/g/min]; p<0.05). By univariate analysis, CVR during CPT was correlated with LDL cholesterol (r=0.38, p<0.05), IL-6 (r=0.46, p<0.02), and TNF-alpha (r=0.39, p<0.05) in hypertensive patients. By multivariate analysis, IL-6 and TNF-alpha were significant independent predictors of CVR during CPT. Elevated plasma IL-6 and TNF-alpha levels were independent predictors of coronary endothelial dysfunction in hypertensive patients. These results suggest that plasma IL-6 and TNF-alpha might be useful for identifying the high risk subgroup of hypertensive patients with coronary endothelial dysfunction and provide an important clue to link systemic inflammation to the development of coronary atherosclerosis. 相似文献
949.
Masayoshi Sarai Dagmar Hartung Artiom Petrov Jun Zhou Navneet Narula Leo Hofstra Frank Kolodgie Satoshi Isobe Shinichiro Fujimoto Jean-Luc Vanderheyden Renu Virmani Chris Reutelingsperger Nathan D Wong Sudhir Gupta Jagat Narula 《Journal of the American College of Cardiology》2007,50(24):2305-2312
OBJECTIVES: The purpose of this study was to evaluate the role of caspase inhibitors on acute resolution of apoptosis in atherosclerotic lesions as evaluated by imaging with annexin A5. BACKGROUND: Extensive apoptosis of macrophages has been reported at the site of plaque rupture in patients dying of acute coronary syndrome. METHODS: Of 31 New Zealand White atherosclerotic rabbits, 6 received broad caspase, 3 received caspase-1, 3 received caspase-3, 3 received caspase-8, and 4 received caspase-9 inhibitors; 12 animals did not receive any caspase inhibitors (treatment control group). Six unmanipulated rabbits were used for comparison (disease control group). Technetium-99m-labeled annexin A5 was used for imaging atherosclerotic lesions; 6 of the 12 uninhibited atherosclerotic rabbits received (99m)Tc-labeled mutant annexin A5 (radiotracer control group). Gamma images were obtained, and quantitative radiotracer uptake was compared with pathologic findings. RESULTS: Atherosclerotic lesions were best visible in untreated atherosclerotic rabbits. Quantitative annexin uptake, defined as the percent of injected dose per g of abdominal aorta tissue, was significantly higher in untreated atherosclerotic animals (mean +/- SD = 0.0515 +/- 0.0099) compared with the normal rabbits (0.0065 +/- 0.0008; p < 0.0001) or atherosclerotic rabbits receiving mutant annexin (0.014 +/- 0.0024; p < 0.0001). Among all caspase inhibitor-treated rabbits, uptake was 39% lower (0.0314 +/- 0.0151) than in untreated atherosclerotic animals (p < 0.01). Uptake was also significantly lower in rabbits receiving broad caspase (0.0206 +/- 0.0058; p < 0.0001) or caspase-1, -3, or -9 (0.0272 +/- 0.0088, p < 0.01; 0.0286 +/- 0.0095, p < 0.01; 0.0300 +/- 0.0021, p < 0.01, respectively) inhibitors. Caspase-8 inhibitor did not affect apoptosis (0.0618 +/- 0.0047; p = NS). Upon histologic characterization, a substantial decrease in macrophage apoptosis was observed in caspase-inhibited animals. CONCLUSIONS: Molecular imaging, using radiolabeled annexin A5, allows the detection of acute resolution of apoptosis as a result of caspase inhibition in experimental atherosclerosis. If proven clinically, this may allow development of novel intervention strategies in acute vascular events. 相似文献
950.
Jun Watanabe Kenji Tatsumi Mitsuyoshi Ota Yusuke Suwa Shinsuke Suzuki Akira Watanabe Atsushi Ishibe Kazuteru Watanabe Hirotoshi Akiyama Yasushi Ichikawa Satoshi Morita Itaru Endo 《International journal of colorectal disease》2014,29(3):343-351